Metformin as an Adjunctive Therapy for the Treatment of Metastatic Colorectal Cancer Patients Undergoing FOLFIRI Plus Target Therapy

Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 2
SUMMARY

To investigate progression-free survival (PFS) in patients with metastatic colorectal cancer treated with chemotherapy FOLFIRI monotherapy or chemotherapy FOLFIRI combined with Metformin

Eligibility
Participation Requirements
Sex: All
Minimum Age: 20
Maximum Age: 90
Healthy Volunteers: f
View:

• Aged between 20 and 90 years old

• Patients diagnosed with metastatic colorectal cancer who is going to receive FOLFIRI chemotherapy

• Female must not be planning to become pregnant or breastfeeding, and not pregnant at any point during treatment. (Contraception is required to participate in this trial)

• Those without major physiological diseases (example of major cardiovascular disease is acute myocardial infarction; example of major cerebrovascular disease is acute stroke, malignant hypertension, acute kidney failure, acute liver failure)

• Those who are not allergic to the relevant drugs required for the test

• Those who can follow the doctor's order to take the medicine

• Subjects must be willing to sign the consent form

• Blood sugar level above 80 mg/dL

Locations
Other Locations
Taiwan
Chung-Ho Memorial Hospital, Kaohsiung Medical University:
RECRUITING
Kaohsiung City
Time Frame
Start Date: 2022-10-31
Estimated Completion Date: 2025-12-31
Participants
Target number of participants: 110
Treatments
Experimental: Study group
Metformin 500mg TID、FOLFIRI (Leucovorin 200 mg/m2、5-FU 2800 mg/m2、Irinotecan 180 mg/m2) plus target therapy
Placebo_comparator: Control group
FOLFIRI (Leucovorin (LV), 200 mg/m2, 2-hour infusion, 5-FU, 2,800 mg/m2, 46-hour infusion, Irinotecan (IRI), 180 mg/m2, 2-hour infusion) plus target therapy
Related Therapeutic Areas
Sponsors
Leads: Kaohsiung Medical University Chung-Ho Memorial Hospital

This content was sourced from clinicaltrials.gov

Similar Clinical Trials